A bipartisan group of U.S. representatives is seeking answers about why the federal government is seemingly favoring foreign marijuana suppliers while stalling the approval of additional...
A bill that would have allowed California marijuana merchants to give product away free of charge to low-income people was one of a slew of drug...
Last week’s decision by the U.S. Drug Enforcement Administration (DEA) to place a marijuana-derived drug in the least restrictive category under federal law was largely based...
Missouri is proving to be one of the most consequential battlegrounds in Democrats’ fight to regain control of the U.S. Senate, with polls showing Democratic incumbent...
The fate of federal marijuana policy reform is squarely in the hands of President Donald Trump, no matter what happens in November’s midterm elections, House Minority...
The number two U.S. House Democrat supports making medical marijuana available and says ending criminalization more broadly “probably makes sense,” but acknowledges that party leaders have...
The Drug Enforcement Administration (DEA) placed a marijuana-derived drug in Schedule V of the Controlled Substances Act on Thursday. The medication, Epidiolex, contains purified cannabidiol (CBD),...
The powerful House Rules Committee has blocked lawmakers from voting on another marijuana-related measure. This time, the panel prevented an amendment to allow cannabis growers, sellers...
In the race for Maine’s U.S. Senate seat, Republican State Sen. Eric Brakey has made marijuana a front-and-center issue, positioning himself as more pro-reform than his...
U.S. Rep. Pete Sessions (R-TX) is facing his first major congressional reelection challenge in over a decade, and his opponent, Democratic candidate Colin Allred, is hot...
